Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RUMA launches companion animal and equine progress report
The report details 12 months of work by the RUMA CA&E Targets and Measures Working Group.

The report details national metrics for measuring antibiotic use in dogs and cats. 

The RUMA Companion Animal and Equine Alliance (RUMA C&E) has released its first Annual Progress Report detailing national metrics for measuring antibiotic use in dogs and cats.

Highlighting 12 months of work by the newly-formed RUMA CA&E Targets and Measures Working Group (T&MWG), the report also identifies four priority areas for tackling antibiotic use in companion animals, including:

  • cat bite acscess
  • kennel cough
  • acute diarrhoea
  • cat flu.

The scenarios are based on areas where there is thought to be the most scope for improving antibiotic stewardship, especially when using the Highest Priority Critically Important Antibiotics.

Established in 2020, the RUMA C&E was formed to define the principles of responsible use of medicines in the companion animal and equine sectors, with a view to positively contributing to the One Health Agenda. With input from stakeholders, including the T&MWG, the report identifies three focus areas for measuring antibiotic use in dogs and cats, namely:

  • reducing the inappropriate use of antibiotics in the companion animal sector at a national and practice level
  • data collection and protocols at a practice level
  • promoting best practice and knowledge exchange.

RUMA CA&E chair Gwyn Jones, said: “These are important building blocks we are putting in place which will provide benchmarks and baselines, and in time, evidence of progress towards achieving the Government’s 20-year vision and five-year national plan for how the UK will contribute to containing and controlling AMR.

“Whilst we acknowledge there are many complex challenges to take into account across the companion animal and equine sectors when it comes to antibiotic stewardship, what is recognised is the opportunity that exists to make a positive impact on AMR and protect the role of antibiotics in both human and animal health for the future.”

The findings of the report will help inform the foundation of ongoing work, including the creation of an Independent Scientific Group (ISC), understanding the capabilities for standardising data and recording drug availability and prevalence data on conditions that require antibiotics.


The full report is available at rumacae.co.uk

Image (C) RUMA.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.